Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of human umbilical cord mesenchymal stem cell injection in moderate to severe ulcerative colitis
CTR20244387Phase 2Active
- Sponsor
- Qingdao Aoke Biological Development
- Start
- Mar 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in autoimmune colitis, sponsored by Qingdao Aoke Biological Development. Started Mar 2025; status: active.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20244387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244387.